Español
India
Italiano
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
PTC Therapeutics
(NASDAQ:PTCT)
Intraday
$37.48
-0.21
[-0.56%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$37.48
-0.21
[-0.56%]
Last update: 3:20PM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for PTC Therapeutics Stock (NASDAQ:PTCT)
PTC Therapeutics Stock (NASDAQ: PTCT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, May 28, 2024
Goldman Sachs Maintains Sell on PTC Therapeut...
Benzinga Newsdesk
PTC Therapeutics Announces The Sepiapterin MA...
Benzinga Newsdesk
Tuesday, May 21, 2024
Citigroup Maintains Sell on PTC Therapeutics,...
Benzinga Newsdesk
JP Morgan Maintains Overweight on PTC Therape...
Benzinga Newsdesk
Goldman Sachs Maintains Sell on PTC Therapeut...
Benzinga Newsdesk
PTC Therapeutics Reports The European Commiss...
Benzinga Newsdesk
Monday, May 20, 2024
Jefferies Maintains Buy on PTC Therapeutics, ...
Benzinga Newsdesk
Why Virios Therapeutics Shares Are Trading Lo...
Avi Kapoor
European Commission Requests Reevaluation Of ...
Vandana Singh
Overseas Shipholding, Micron, Squarespace, In...
Avi Kapoor
Market-Moving News for May 20th
Benzinga Newsdesk
PTC Therapeutics shares are trading higher af...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-...
Benzinga Insights
PTC Therapeutics Paused 2024 Revenue Guidance...
Benzinga Newsdesk
PTC Therapeutics Announces European Commissio...
Benzinga Newsdesk
Tuesday, May 14, 2024
PTC Therapeutics shares are trading higher af...
Benzinga Newsdesk
PTC Therapeutics Announces FDA Acceptance And...
Benzinga Newsdesk
Monday, April 29, 2024
PTC Therapeutics shares are trading higher af...
Benzinga Newsdesk
Morgan Stanley Upgrades PTC Therapeutics to E...
Benzinga Newsdesk
Friday, April 26, 2024
PTC Therapeutics shares are trading higher af...
Benzinga Newsdesk
Thursday, April 25, 2024
PTC Therapeutics Reaffirms FY24 Financial Gui...
Benzinga Newsdesk
PTC Therapeutics Says On Target To Achieve Re...
Benzinga Newsdesk
PTC Therapeutics Q1 2024 GAAP EPS $(1.20) Bea...
Benzinga Newsdesk
Friday, April 12, 2024
Cantor Fitzgerald Reiterates Overweight on PT...
Benzinga Newsdesk
Thursday, March 28, 2024
PTC Therapeutics Submits Sepiapterin MAA For ...
Benzinga Newsdesk
Friday, March 08, 2024
RBC Capital Reiterates Sector Perform on PTC ...
Benzinga Newsdesk
Friday, March 01, 2024
PTC Therapeutics shares are trading higher af...
Benzinga Newsdesk
Cooper Companies Reports Upbeat Results, Join...
Avi Kapoor
RBC Capital Maintains Sector Perform on PTC T...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on PT...
Benzinga Newsdesk
TD Cowen Maintains Market Perform on PTC Ther...
Benzinga Newsdesk
Thursday, February 29, 2024
PTC Therapeutics Sees FY24 Revenue $600M-$680...
Benzinga Newsdesk
Recap: PTC Therapeutics Q4 Earnings
Benzinga Insights
PTC Therapeutics Q4 2023 Adj EPS $(0.240) Mis...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 28, 2024
Earnings Preview: PTC Therapeutics
Benzinga Insights
Friday, January 26, 2024
Cantor Fitzgerald Maintains Overweight on PTC...
Benzinga Newsdesk
RBC Capital Maintains Sector Perform on PTC T...
Benzinga Newsdesk
PTC Therapeutics To Withdraw Its Conditionall...
Vandana Singh
PTC Therapeutics shares are trading lower aft...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-...
Benzinga Insights
Thursday, January 25, 2024
PTC Therapeutics shares are trading lower aft...
Benzinga Newsdesk
CHMP Issues Negative Opinion For Renewal Of C...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Af...
Benzinga Insights
Monday, January 08, 2024
PTC Therapeutics Sees FY24 Revenue $600M-$850...
Benzinga Newsdesk
PTC Therapeutics Sees FY23 Revenue ~$946M Vs ...
Benzinga Newsdesk
Tuesday, December 19, 2023
Morgan Stanley Downgrades PTC Therapeutics to...
Benzinga Newsdesk
Monday, December 18, 2023
Cantor Fitzgerald Reiterates Overweight on PT...
Benzinga Newsdesk
Tuesday, December 05, 2023
PTC Therapeutics Updates On Translarna (Atalu...
Benzinga Newsdesk
Monday, November 20, 2023
Analyst Expectations for PTC Therapeutics's F...
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch